Does hemoglobin A1c (HbA1c) have a relationship with celiac disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does A1c and Celiac Disease Relate?

Yes, A1c and celiac disease are directly related in patients with type 1 diabetes—celiac disease can cause unpredictable blood glucose levels, unexplained hypoglycemia, and deterioration in glycemic control, while also potentially interfering with accurate A1c measurement due to malabsorption-related anemia. 1

The Clinical Relationship

Impact on Glycemic Control

Celiac disease affects A1c through two distinct mechanisms:

Direct glycemic effects: Untreated celiac disease causes malabsorption of nutrients, leading to unpredictable glucose absorption patterns. This manifests as:

  • Unexplained hypoglycemia episodes
  • Erratic blood glucose fluctuations
  • Deterioration in previously stable glycemic control 1

The most recent pediatric data from 2026 demonstrates that children with both type 1 diabetes and celiac disease have significantly higher rates of uncontrolled diabetes (89.1% vs. 73.8%, p=0.0006), with celiac disease independently associated with uncontrolled A1c (adjusted OR: 2.59; 95% CI: 1.37-4.90) 2. Notably, patients with villous atrophy at diagnosis had significantly higher A1c levels after one year 3.

Measurement interference: Celiac disease can alter the accuracy of A1c testing itself. The malabsorption causes iron-deficiency anemia and affects red blood cell turnover, which directly interferes with A1c measurement reliability 4, 5, 6. In conditions with altered red blood cell turnover, only plasma blood glucose criteria should be used to diagnose or monitor diabetes 4, 5, 7.

The Epidemiologic Connection

The prevalence of celiac disease in type 1 diabetes patients is substantially elevated:

  • 5.4% of individuals with type 1 diabetes in the United States have circulating tissue transglutaminase antibodies 1
  • General population prevalence: 0.3-1% 1
  • Pediatric studies show 4.6-10.3% prevalence in type 1 diabetes cohorts 2, 8

Screening and Diagnostic Approach

When to Screen

Screen all patients with type 1 diabetes for celiac disease using tissue transglutaminase (tTG) antibodies with documentation of normal serum IgA levels 1. Testing should occur:

  • Soon after diabetes diagnosis
  • Subsequently if growth failure, failure to gain weight, weight loss, or gastrointestinal symptoms occur
  • When unexplained hypoglycemia or deteriorating glycemic control develops 1

Interpreting Results

Critical thresholds for diagnosis:

  • All patients with positive EMA and TTG-IgA ≥8 times upper limit of normal were diagnosed with celiac disease 9
  • Very elevated and confirmed IgA tTG levels require referral to gastroenterology for small-bowel biopsy 1
  • Low to moderately positive levels should be repeated every 6-12 months 1

Important caveat: IgA deficiency occurs in 1-3% of celiac disease patients (versus 1 in 500 in general population), causing falsely low IgA-based test results. Always obtain quantitative serum IgA levels at screening 1.

Effect of Gluten-Free Diet on A1c

The evidence on gluten-free diet impact is mixed:

Contradictory findings exist:

  • Some studies show no significant change in A1c before and after gluten-free diet therapy 8
  • However, untreated celiac disease with villous atrophy is associated with worsening glycemic control 3
  • Interestingly, one large registry study found that coexisting type 1 diabetes and celiac disease was associated with lower A1c compared to type 1 diabetes alone (8.5% vs 8.7%, p<0.001) 10

The clinical reality: Even without dramatic A1c improvements, gluten-free diet may prevent unexpected hypoglycemia due to absorptive abnormalities and prevent other nutritional, metabolic, and oncologic consequences of celiac disease 1.

Clinical Management Algorithm

  1. At type 1 diabetes diagnosis: Screen with tTG IgA + total IgA level
  2. If positive: Confirm with repeat testing before initiating gluten-free diet
  3. If confirmed elevated: Refer to gastroenterology for small-bowel biopsy (even if asymptomatic)
  4. If biopsy-proven celiac disease: Initiate gluten-free diet with registered dietitian experienced in both conditions 1
  5. Monitor A1c reliability: If discordance between A1c and glucose measurements develops, use plasma glucose criteria instead 4, 5, 6
  6. Expect lower insulin requirements: Children with celiac disease have significantly lower insulin doses at diagnosis 3

Key Pitfalls to Avoid

  • Don't rely on symptoms alone: Many children with type 1 diabetes and elevated tTG are asymptomatic or have subtle symptoms 1
  • Don't start gluten-free diet before testing: All diagnostic serologic testing must be performed before dietary changes 11
  • Don't use A1c alone in confirmed celiac disease: Consider alternative monitoring with self-monitoring of blood glucose, CGM, or glycated serum protein assays if anemia or malabsorption is present 6
  • Don't overlook growth parameters: Patients with celiac disease have significantly lower weight, height, and BMI at diagnosis 3, 8

References

Research

Interpreting positive celiac serology in children with new-onset type 1 diabetes.

Journal of pediatric endocrinology & metabolism : JPEM, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.